Scribe Therapeutics Inc. carries a market capitalization of 342.90M, placing it among publicly traded companies globally.
| Market Cap | 342.90M |
| Enterprise Value | N/A |
Scribe Therapeutics Inc.'s stock has gained approximately 41.26667% over the past 52 weeks. The 50-day moving average sits at 21.72, while the 200-day moving average is 21.72.
| Beta (5Y) | N/A |
| 52-Week Price Change | 41.26667% |
| 50-Day Moving Average | 21.72 |
| 200-Day Moving Average | 21.72 |
| Average Volume (20 Days) | N/A |